The Journal. · Monday, June 29, 2026
The demand for GLP-1 drugs for weight loss has surged, with utilization doubling or tripling in some areas. This rapid increase in usage, even after price cuts, is a significant factor in rising healthcare costs for municipal employees.
“Utilization of them has sky-rocketed.”
“And in a lot of these kind of audit reports that the towns talk about, um, they were getting, you know, notes from their health insurance brokers just saying that the usage of these drugs had doubled or tripled or, um, more over the course of a few years.”
“Even after recent price cuts, these drugs can still cost insurers hundreds of dollars a month for each patient.”